PDL BioPharma, Inc. PDLI

Other  —  Other
Market cap
—
P/E
0.0×
Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
— 0.00 0.00 3.99 5.72
P/S ratio
— 7.04 2.13 1.39 1.50
P/FCF ratio
— 5.49 5.80 3.04 3.18
P/Operating CF
— (20.14) (204.47) (25.57) 23.34
P/B ratio
— 0.65 0.58 0.53 0.48
Price to Tangible BV
— 0.66 1.40 1.59 2.93
EV/Sales
— 4.45 0.77 0.10 1.46
EV/EBITDA
— 0.00 0.00 0.13 2.35
EV/Operating CF
— (7.52) (11.36) 0.77 3.50
EV/FCF
— 3.47 2.09 0.21 3.10
Quick Ratio
— 4.53 7.93 2.92 2.17
Current Ratio
— 6.87 9.86 3.32 3.05
Net Debt/EBITDA
— 2.02 11.51 (1.79) (0.06)
Debt/Assets
0.00% 3.81% 12.93% 9.45% 19.13%
Debt/Equity
— 0.05 0.17 0.14 0.31
Asset Turnover
0.00 0.07 0.18 0.26 0.22
Operating CF/Net income
— 0.46 0.20 0.37 1.60
Capex/Depreciation
— 4.70 1.97 2.78 0.59
Interest Coverage
— 0.00 0.00 0.00 0.00
ROE
— (10.64%) (8.74%) 13.83% 8.76%
ROA
0.00% (8.38%) (6.24%) 9.01% 5.71%
ROIC
— (14.61%) (6.88%) 28.09% 10.85%
Return on Tangible Assets
— (25.72%) (14.58%) 24.36% 23.76%
Average Days of Receivables
— 90.34 39.88 35.56 59.94
Research and Development Expense of Revenue
— 13.35% 1.49% 2.31% 1.56%
Selling, General and Administrative Expense of Revenue
— 98.76% 31.58% 19.79% 16.51%
Intangible Assets out of Total Assets
0.00 0.40 0.44 0.45 0.52
Share Based Compensation of Revenue
— 13.00% 2.40% 0.98% 1.53%
Graham Net Nets
— 0.49 0.67 0.55 (0.17)
Graham Number
— 0.00 0.00 9.39 6.36
Earnings Yield
— (19.38%) (15.52%) 25.09% 17.49%
Free Cash Flow Yield
— 18.23% 17.25% 32.87% 31.42%
Revenue per Share
— 0.46 1.36 2.06 1.49
Operating CF per Share
— (0.27) (0.09) 0.26 0.62
Capex per Share
— 0.69 0.37 0.68 0.08
Free Cash Flow per Share
— 0.42 0.27 0.94 0.70
Cash per Share
— 1.63 2.71 3.42 1.48
Shareholders Equity per Share
— 5.00 5.01 5.44 4.61
Interest Debt per Share
— 0.00 0.00 0.00 0.00
Book value per Share
— 5.00 5.01 5.44 4.61
Free Cash Flow
— 49.37 40.02 146.58 114.78
Working Capital
— 268.20 464.75 447.33 267.72
Capital Expenditures
— 81.81 53.45 105.96 13.06
Net Current Asset Value
— 191.05 283.26 243.21 (61.93)
EV/EBIT
— 0.00 0.00 0.16 2.75
Capex to Sales
— (1.49) (0.27) (0.33) (0.05)
Net Profit Margin
— (128.59%) (34.76%) 34.60% 26.04%
Price to Operating Income
— 0.00 0.00 2.30 2.82
Other line items
Depreciation/Fixed assets
— 3.15 3.67 5.27 580.39
Cash ROIC
— (4.66%) (1.67%) 2.23% 8.27%
Accounts Receivable Turnover
— 3.11 7.50 8.98 12.09
Accounts Payable Turnover
— 3.51 2.94 2.28 1.10
Inventory Turnover
— 1.83 3.45 5.08 0.68
Average Days of Payables
— 118.24 98.99 236.48 629.97
Days of Inventory on Hand
— 270.75 142.67 109.33 258.96
Average Receivables
— 17.60 26.42 35.65 20.21
Average Payables
— 15.26 16.46 13.40 3.71
Average Inventory
— 29.36 14.04 6.02 6.02
Average Assets
358.06 839.93 1,103.43 1,229.26 1,113.80
Average Common Equity
— 661.53 787.83 800.66 725.69

Fold the line items

Columns are period end dates